- The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. Kazda, C., Gallwitz, B., Simó, R., Guzmán, J.R., Kraus, P., Nicolay, C., Rose, L., Schernthaner, G. Diabetes. Obes. Metab (2009)